| Cover | Feb. 25, 2025 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Feb. 25, 2025 |
| Entity File Number | 001-41264 |
| Entity Registrant Name | Nuvectis Pharma, Inc. |
| Entity Central Index Key | 0001875558 |
| Entity Tax Identification Number | 86-2405608 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 1 Bridge Plaza Suite 275 |
| Entity Address, City or Town | Fort Lee |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 07024 |
| City Area Code | 201 |
| Local Phone Number | 614-3150 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock |
| Trading Symbol | NVCT |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
